Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients

SUMMARY: Outcomes for melanoma patients with stage III disease differ widely even within the same subcategory. Molecular signatures that more accurately predict prognosis are needed to stratify patients according to risk. Proteomic analyses were used to identify differentially abundant proteins in e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pigment Cell Melanoma Res
Autors principals: Mactier, Swetlana, Kaufman, Kimberley L, Wang, Penghao, Crossett, Ben, Pupo, Gulietta M, Kohnke, Philippa L, Thompson, John F, Scolyer, Richard A, Yang, Jean Y, Mann, Graham J, Christopherson, Richard I
Format: Artigo
Idioma:Inglês
Publicat: BlackWell Publishing Ltd 2014
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4285183/
https://ncbi.nlm.nih.gov/pubmed/24995518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12290
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars